Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?

Sneha Mishra, MBBS, Patress A. Persons, MD and Sophie Bersoux, MD, MPH
Cleveland Clinic Journal of Medicine April 2025, 92 (4) 209-211; DOI: https://doi.org/10.3949/ccjm.92a.24110
Sneha Mishra
Division of Community Internal Medicine, Mayo Clinic, Scottsdale, AZ; Assistant Professor, Mayo Clinic College of Medicine and Science, Scottsdale, AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Patress A. Persons
Division of Community Internal Medicine, Mayo Clinic, Scottsdale, AZ; Assistant Professor, Mayo Clinic College of Medicine and Science, Scottsdale, AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Bersoux
Division of Community Internal Medicine, Mayo Clinic, Scottsdale, AZ; Assistant Professor, Mayo Clinic Alix School of Medicine-Arizona Campus, Scottsdale, AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 92 no. 4 209-211
DOI 
https://doi.org/10.3949/ccjm.92a.24110
PubMed 
40169221

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online April 1, 2025.

Copyright & Usage 
Copyright © 2025 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Sneha Mishra, MBBS⇑
  1. Division of Community Internal Medicine, Mayo Clinic, Scottsdale, AZ; Assistant Professor, Mayo Clinic College of Medicine and Science, Scottsdale, AZ
  1. Address:
    Sneha Mishra, MBBS, Division of Community Internal Medicine, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, AZ 85259; mishra.sneha{at}mayo.edu
  1. Patress A. Persons, MD
  1. Division of Community Internal Medicine, Mayo Clinic, Scottsdale, AZ; Assistant Professor, Mayo Clinic College of Medicine and Science, Scottsdale, AZ
  1. Sophie Bersoux, MD, MPH
  1. Division of Community Internal Medicine, Mayo Clinic, Scottsdale, AZ; Assistant Professor, Mayo Clinic Alix School of Medicine-Arizona Campus, Scottsdale, AZ
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 92 (4)
Cleveland Clinic Journal of Medicine
Vol. 92, Issue 4
1 Apr 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?
Sneha Mishra, Patress A. Persons, Sophie Bersoux
Cleveland Clinic Journal of Medicine Apr 2025, 92 (4) 209-211; DOI: 10.3949/ccjm.92a.24110

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?
Sneha Mishra, Patress A. Persons, Sophie Bersoux
Cleveland Clinic Journal of Medicine Apr 2025, 92 (4) 209-211; DOI: 10.3949/ccjm.92a.24110
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • WHY CONSIDER HOLDING GLP-1 RECEPTOR AGONISTS BEFORE SURGICAL PROCEDURES?
    • WHAT FACTORS SHOULD INFORM THE DECISION TO HOLD GLP-1 RECEPTOR AGONISTS BEFORE AN ELECTIVE SURGICAL PROCEDURE?
    • WHAT ARE RECOMMENDATIONS FOR HOLDING GLP-1 RECEPTOR AGONISTS BEFORE AN ELECTIVE SURGICAL PROCEDURE?
    • WHAT ARE RECOMMENDATIONS FOR HOLDING GLP-1 RECEPTOR AGONISTS BEFORE AN ENDOSCOPIC PROCEDURE?
    • THE BOTTOM LINE
    • DISCLOSURES
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Do I need to treat supine hypertension in my hospitalized patient?
  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Diabetes
  • Endocrinology
  • Hospital Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire